Vasopressors & The Older Patient - The 65 Trial

April 27, 2020 00:22:04
Vasopressors & The Older Patient - The 65 Trial
Critical Care Perspectives in Emergency Medicine
Vasopressors & The Older Patient - The 65 Trial

Apr 27 2020 | 00:22:04

/

Show Notes

Current guidelines for many critical illnesses recommend targeting a MAP of 65 mm Hg, with consideration of higher MAPs in older patients with chronic HTN. Recent literature, however, suggests increased mortality in older patients who are exposed to larger quantities of vasopressor medications.  In this podcast, we do a deep dive into the recently published 65 Trial, which sought to evaluate the effect of permissive hypotension in older patients with vasodilatory hypotension.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

October 04, 2022 00:25:21
Episode Cover

Does a Restrictive Oxygenation Target Make a Difference in the Post-Arrest Patient?

The care of patients with return of spontaneous circulation following cardiac arrest centers on optimizing oxygenation and ventilation, optimizing hemodynamics, identifying patients that require...

Listen

Episode 0

August 28, 2018 00:27:45
Episode Cover

Steroids for Septic Shock - Take 2

In February, we discussed the results of the ADRENAL trial and implications for clinical practice.  Since that time, another large trial and meta-analysis has...

Listen

Episode 0

February 04, 2020 00:20:31
Episode Cover

Identifying and Treating EVALI

In recent years, the use of e-cigarette and vaping products has sharply risen.  Concomitant with the increased use is an increase in patients presenting...

Listen